Ten-year incidence and progression of age-related maculopathy: The Beaver Dam eye study.
about
Statins for age-related macular degenerationStatins for age-related macular degenerationSurgical implantation of steroids with antiangiogenic characteristics for treating neovascular age-related macular degenerationStatins for age-related macular degenerationMacular translocation for neovascular age-related macular degenerationSubmacular surgery for choroidal neovascularisation secondary to age-related macular degenerationAntiangiogenic therapy with anti-vascular endothelial growth factor modalities for neovascular age-related macular degenerationSurgical implantation of steroids with antiangiogenic characteristics for treating neovascular age-related macular degenerationAntiangiogenic therapy with interferon alfa for neovascular age-related macular degenerationAntiangiogenic therapy with anti-vascular endothelial growth factor modalities for neovascular age-related macular degenerationInterferon alfa therapy for age-related macular degenerationEpithelial membrane protein 2 controls VEGF expression in ARPE-19 cellsRisk factors for the incidence of Advanced Age-Related Macular Degeneration in the Age-Related Eye Disease Study (AREDS) AREDS report no. 19Folic acid, pyridoxine, and cyanocobalamin combination treatment and age-related macular degeneration in women: the Women's Antioxidant and Folic Acid Cardiovascular StudyCFH Y402H confers similar risk of soft drusen and both forms of advanced AMDStatins for age-related macular degenerationClinical applications of optical coherence tomography in the posterior pole: the 2011 José Manuel Espino Lecture - Part IIAnimal models of age related macular degenerationAdhesion failures determine the pattern of choroidal neovascularization in the eye: a computer simulation studyRecent developments in the management of dry age-related macular degenerationAssociations between lutein, zeaxanthin, and age-related macular degeneration: an overviewAge-related macular degeneration and the incidence of cardiovascular disease: a systematic review and meta-analysisDissection of genomewide-scan data in extended families reveals a major locus and oligogenic susceptibility for age-related macular degenerationThe relationship of atherosclerosis to the 10-year cumulative incidence of age-related macular degeneration: the Beaver Dam studies.Examining the relative influence of familial, genetic, and environmental covariate information in flexible risk models.Impact of simulated central scotomas on visual search in natural scenesCone structure imaged with adaptive optics scanning laser ophthalmoscopy in eyes with nonneovascular age-related macular degeneration.Ultrahigh resolution optical coherence tomography in non-exudative age related macular degenerationHarmonizing the classification of age-related macular degeneration in the three-continent AMD consortium.The complexities underlying age-related macular degeneration: could amyloid beta play an important role?Risk factors for age-related maculopathyMarkers of inflammation, oxidative stress, and endothelial dysfunction and the 20-year cumulative incidence of early age-related macular degeneration: the Beaver Dam Eye Study.The prevalence and analysis of risk factors for age-related macular degeneration: 18-year follow-up data from the Speedwell eye study, United Kingdom.Characteristics of age-related macular degeneration in patients with diabetic retinopathy.Vitamin E and age-related macular degeneration in a randomized trial of women.A whole-genome screen of a quantitative trait of age-related maculopathy in sibships from the Beaver Dam Eye StudyAge-related macular degeneration--a genome scan in extended families.The prevalence of macular telangiectasia type 2 in the Beaver Dam eye study.Quantitative comparison of drusen segmented on SD-OCT versus drusen delineated on color fundus photographsEarly signs of exudative age-related macular degeneration in Asians
P2860
Q24188161-E503FB82-DA4A-4F06-A406-3C2BBF1DDF11Q24201178-8A14A5AE-E364-426C-AE4B-41219488C68AQ24201624-60B919A9-80AA-4BA7-BA6F-6C920A4463CFQ24240102-061DC153-B22F-4738-86D3-782F0AC51CD5Q24241142-5647CD52-DE66-413E-B66C-4F75B501A743Q24241790-FC33EE1A-B88B-4E4E-91B6-D2C73E7CDCDBQ24243234-E49A2BD3-288C-45E9-9253-3E0409BBBC4FQ24243503-294ADF00-C28D-4679-B929-3F17504D04D5Q24244534-3EF01B15-A963-44E5-9646-C8B64167F518Q24245483-3D6F6733-3C91-4F61-AB53-9E05E119447AQ24246549-C8F0C82E-8379-43EF-B919-574F3DED96F2Q24320319-84C3DFB0-48F7-4125-BC64-90DF8B9037DEQ24554181-39F9E777-707A-40FD-AA14-21348F660135Q24647967-11B9AD73-13EF-44B4-90E0-45BF088FF563Q24811235-6BB45830-19ED-409E-9249-F66CFAB18B92Q26470515-AE5D4404-C0F1-4476-843A-FD8050F112A7Q26864721-07C8A1CA-0E38-4CEC-BBA6-EDF9CAC0927BQ27004686-266AC9C9-A188-42C9-86FD-283E025AF89AQ27331651-7C0A5CFD-F417-4D06-AC39-CBF1DD68EA44Q28088816-6A849114-73D2-4725-BF70-6A3C6C29485FQ28235987-C23973D9-6416-442A-B94C-D9FDD04C8E3BQ28660578-9562FB47-3BE8-4E84-9FEF-287122257459Q28769548-5F9B19DF-E42C-454A-B4DF-E7817FD9A2E8Q30439266-2179F181-2B37-451C-89D3-FB292EB8C334Q30487424-5FB69DC7-4951-4697-B5E7-3133C156BD45Q30524658-9BCFCA36-1300-4173-B3A0-B6651ACC0F71Q30557413-FBE787FF-BE36-411F-ADFC-D226F972ED73Q33232109-5377A6BD-9DAA-4F63-BF78-05D5DAFEB390Q33643633-48D8F47E-0394-40FA-8538-597BF9AF9D60Q33702571-E36842FF-64F9-441F-B49C-DB0E86BA2899Q33720834-86C18C39-966A-4E15-9F18-74F83BCC1395Q33824902-2C167BAF-52FC-490F-84EC-9718616F22E4Q33855388-B551D85F-3F94-4E97-9256-FF399A7579C6Q33888124-1B1BADAB-8A95-4DE9-B6B9-B5499E7AE77FQ33895488-293350F8-3BCB-4962-A308-A8C3F0002E32Q33904829-E9073604-6162-4887-93EC-F5DC69BA0937Q33906317-0877ABB9-3DC7-4FBE-AD7E-18D2D5C222D6Q33984142-E79B8640-C06F-44BF-99A6-6A4B3B479DACQ34127143-9723725E-FA33-4E94-8AE4-988E84DED061Q34293886-5A384A0A-C0E5-4C91-9654-77F668446849
P2860
Ten-year incidence and progression of age-related maculopathy: The Beaver Dam eye study.
description
2002 nî lūn-bûn
@nan
2002年の論文
@ja
2002年学术文章
@wuu
2002年学术文章
@zh
2002年学术文章
@zh-cn
2002年学术文章
@zh-hans
2002年学术文章
@zh-my
2002年学术文章
@zh-sg
2002年學術文章
@yue
2002年學術文章
@zh-hant
name
Ten-year incidence and progression of age-related maculopathy: The Beaver Dam eye study.
@en
Ten-year incidence and progression of age-related maculopathy: The Beaver Dam eye study.
@nl
type
label
Ten-year incidence and progression of age-related maculopathy: The Beaver Dam eye study.
@en
Ten-year incidence and progression of age-related maculopathy: The Beaver Dam eye study.
@nl
prefLabel
Ten-year incidence and progression of age-related maculopathy: The Beaver Dam eye study.
@en
Ten-year incidence and progression of age-related maculopathy: The Beaver Dam eye study.
@nl
P2093
P1433
P1476
Ten-year incidence and progression of age-related maculopathy: The Beaver Dam eye study.
@en
P2093
Barbara E K Klein
Guan-Hua Huang
Sandra C Tomany
Stacy M Meuer
P304
P356
10.1016/S0161-6420(02)01146-6
P50
P577
2002-10-01T00:00:00Z